Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ARHGAP11A-DT (ARHGAP11A divergent transcript) is a non-coding RNA gene located in the human genome, named as the divergent transcript of the ARHGAP11A gene. It does not encode a protein and there is currently no direct evidence regarding its biological function, role in disease, or therapeutic relevance. ARHGAP11A-DT is not classified as a receptor, enzyme, transporter, nor is it targeted by any known drug interventions. Its nomenclature reflects its genomic arrangement relative to the protein-coding ARHGAP11A gene, but no functional or disease-linked information is currently attributed to ARHGAP11A-DT in scientific resources or databases.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ARHGAP11A divergent transcript (ARHGAP11A-DT).